Central retinal thickness measured with HD-OCT shows a weak correlation with visual acuity in eyes with CSME

Aims To investigate the correlation between increased retinal thickness (RT) measured with spectral domain high-definition optical coherence tomography (OCT) (Cirrus HD-OCT (Carl Zeiss Meditec, Dublin, California, USA)) and best-corrected visual acuity (BCVA) in eyes with clinically significant macular oedema (CSME) and type 2 diabetes. Methods Seventy eyes with CSME were included in this observational study. Sixty-two eyes were considered for analysis and were classified as having/not having retinal thickening in the central fovea (central 500-μm-diameter circle) by Cirrus HD-OCT. RT measurements were computed and correlated with BCVA. For comparison purposes, the Stratus OCT (Carl Zeiss Meditec, Dublin, California, USA) central point thickness was also obtained in these eyes. Results In the 19 eyes with CMSE identified by Cirrus HD-OCT without increased RT in the central fovea (500-μm-diameter circle), no correlation was found between RT and BCVA (R=0.062; 95% CI −0.404 to 0.502). In the 43 eyes where the Cirrus HD-OCT identified an increased RT in the central fovea (central 500-μm-diameter circle), only a moderate correlation between RT and BCVA was found (R=−0.459; 95% CI −0.667 to −0.184). Conclusion Correlations between RT and BCVA in CSME are only present when the central 500-μm-diameter circle is involved. However, even in this circumstance, a correlation was found in only 48.8% of the cases. RT cannot, therefore, be used as a surrogate outcome for visual acuity changes.

[1]  PHOTOCOAGULATION FOR DIABETIC MACULAR EDEMA: EARLY TREATMENT DIABETIC RETINOPATHY STUDY REPORT NO. 4 , 1987, International ophthalmology clinics.

[2]  F L Ferris,et al.  Photocoagulation for diabetic macular edema. , 1987, Archives of ophthalmology.

[3]  Jennifer I. Lim,et al.  Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema. , 2007, Ophthalmology.

[4]  Early Treatment Diabetic Retinopathy Study design and baseline patient characteristics. ETDRS report number 7. , 1991, Ophthalmology.

[5]  J. R. Landis,et al.  The measurement of observer agreement for categorical data. , 1977, Biometrics.

[6]  W. Goebel,et al.  RETINAL THICKNESS IN DIABETIC RETINOPATHY: A Study Using Optical Coherence Tomography (OCT) , 2002, Retina.

[7]  Ali Erginay,et al.  Optical coherence tomography for evaluating diabetic macular edema before and after vitrectomy. , 2003, American journal of ophthalmology.

[8]  E Reichel,et al.  Quantitative assessment of macular edema with optical coherence tomography. , 1995, Archives of ophthalmology.

[9]  F. Ferris,et al.  Report from the NEI/FDA Ophthalmic Clinical Trial Design and Endpoints Symposium. , 2008, Investigative ophthalmology & visual science.

[10]  M. Isola,et al.  “Light” versus “classic” laser treatment for clinically significant diabetic macular oedema , 2005, British Journal of Ophthalmology.

[11]  Michael J. Campbell,et al.  Statistics at Square One , 1976, British medical journal.

[12]  F. Ferris,et al.  New visual acuity charts for clinical research. , 1982, American journal of ophthalmology.

[13]  Luciano da Fontoura Costa,et al.  Shape Analysis and Classification: Theory and Practice , 2000 .